Evidence from epidemiological studies demonstrates that the prevalence of allergic disease is increasing worldwide; an epidemic largely driven by environmental factors associated with the adoption of a modern, urbanized lifestyle. Changes in early-life intestinal colonization patterns stemming from reduced exposure to traditional environmental microbes have been implicated in the failure of allergic individuals to develop appropriate immunoregulatory networks. Indeed, differences in intestinal microflora composition are observed between allergic and non-allergic persons, and colonization patterns measured within the first few months of life are especially predictive of allergic status. Several environmental factors have been associated with this microbiome imbalance, but there is conflicting evidence as to which exposures are truly driving disruption. Based on evidence linking microbiome perturbation to the pathogenesis of allergic disease, an obvious approach to prevention and treatment of allergy has been the use of probiotics and bacterial by-products (i.e. SCFAs). These interventions have seen some success in animal studies, but current attempts to therapeutically manipulate the microbiome in humans have been largely unable to impact systemic sensitization and alter host allergic status.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Elizabeth Simms, McMaster University
I am a 4th year MD/PhD student at McMaster University. My research is in the field of allergy and immunology, with a focus on peanut-induced anaphylaxis. I am interested in developing a therapy to prevent peanut-induced anaphylaxis in peanut-sensitized individuals, and in studying the associated mechanisms of immune tolerance induction.